CTY — CITY THERAPEUTICS, INC.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 2143850 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
No quarterly fundamentals indexed for this ticker.
Balance + Analyst (yfinance extras)
Retained Earnings
$-142,547,000
Inventory
—
Receivables
$5,119,000
ST Investments
—
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$14,342,000
EBITDA
$-82,997,000
Free Cash Flow
—
Enterprise Value
—
Total Cash
$169,604,992
Total Debt
$57,037,000
Shares Out
48,367,858
Trailing EPS
—
Book Value
$-24.91
ROE
—
ROA
—
Div Yield
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| LLY | ELI LILLY & Co | $1.14T | $1273.46 | — |
| JNJ | JOHNSON & JOHNSON | $635.76B | $263.81 | — |
| ABBV | AbbVie Inc. | $504.76B | $285.64 | — |
| MRK | Merck & Co., Inc. | $358.41B | $145.27 | — |
| NVS | NOVARTIS AG | $287.24B | $151.12 | — |
Recent Insider Activity
| Filed | Trade | Insider | Title | Type | Price | Qty | Value |
|---|---|---|---|---|---|---|---|
| 2026-10-19 17:37:43 | 2026-10-19 | Nelsen Robert | Dir, 10% | P - Purchase | 18 | 170000 | 3060000 |
| 2026-10-19 17:38:59 | 2026-10-19 | Arch Venture Partners Xii, LLC | 10% | P - Purchase | 18 | 170000 | 3060000 |